[{"name":"Sizing the unmet need in the treatment of early HER2-positive breast cancer (ID 796)","mode":"","is_cme":false,"info":{"presentation":"Sizing the unmet need in the treatment of early HER2-positive breast cancer <small>(ID 796)<\/small>","session":"Pierre-Fabre - Industry Satellite Symposium: How to do more to improve HER2-positive early breast cancer patient outcomes? <small>(ID 76)<\/small>","presenter":"Michael Untch<small> (Berlin, Germany)<\/small>","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/breast2020\/persons\/photos\/745.jpg"},"playlist":[{"name":"Sizing the unmet need in the treatment of early HER2-positive breast cancer","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/76\/v\/796_2c.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/breast2020\/76\/v\/796_2c.mp4","cover":"","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/76\/v\/796_2c.vtt","thumbnails":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/76\/v\/796_2c-thumbnails.vtt"}]}]{"provider":"CTI","provider_live":0,"type":1,"code":"7L240eJ02Vk"}